Leap Therapeutics Completes $58.88 Million Private Placement to Launch Digital Asset Finance Strategy

Leap Therapeutics (NASDAQ: LPTX), a biotechnology company, announced that it has completed its previously announced private placement, led by Winklevoss Capital, raising $58,888,888 in cash to launch its digital asset finance strategy. Winklevoss Capital will provide capital and strategic support to help Leap build and execute its digital asset finance strategy.